LXR-mediated ABCA1 expression and function are modulated by high glucose and PRMT2

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Hussein, Maryem A ^a   Shrestha, Elina ^a   Ouimet, Mireille ^a   Barrett, Tessa J ^a   Leone, Sarah ^a   Moore, Kathryn J ^a   Hérault, Yann ^b,c,d,e,f   Fisher, Edward A ^a   Garabedian, Michael J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c CNRS   (France)

^d INSERM   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f INSTITUT CLINIQUE DE LA SOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; DNA METHYLTRANSFERASE 1; GLUCOSE; LIVER X RECEPTOR; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 2; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCA1 PROTEIN, MOUSE; ABCG1 PROTEIN, MOUSE; CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPOPROTEIN; METHYLTRANSFERASE; ORPHAN NUCLEAR RECEPTOR; PRMT2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; UPREGULATION; ANALYSIS; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL LINE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 1; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CELL LINE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; LIVER X RECEPTORS; MACROPHAGES; MALE; METHYLTRANSFERASES; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; PROTEIN-ARGININE N-METHYLTRANSFERASES;

EID: 84942694082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135218     Document Type: Article

References (48)

1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National H, Nutrition Examination S, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003; 52(5):1210-4. Epub 2003/04/30. PMID: 12716754.
2. Chait A, Bornfeldt KE. Diabetes and atherosclerosis: is there a role for hyperglycemia? Journal of lipid research. 2009; 50 Suppl:S335-9. doi: 10.1194/jlr.R800059-JLR200 PMID: 19029122; PubMed Central PMCID: PMC2674740.
3. Dorman JS, Tajima N, LaPorte RE, Becker DJ, Cruickshanks KJ, Wagener DK, et al. The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: case-control analyses of risk factors for mortality. Diabetes care. 1985; 8 Suppl 1:54-60. Epub 1985/09/01. PMID: 4053954.
4. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Bmj. 1998; 316(7134):823-8. Epub 1998/04/29. PMID: 9549452; PubMed Central PMCID: PMC28484.
5. Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000; 102(18):2180-4. Epub 2000/11/01. PMID: 11056089.
6. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr., et al. Trends in cardiovascular complications of diabetes. Jama. 2004; 292(20):2495-9. Epub 2004/11/25. doi: 10.1001/jama.292.20.2495 PMID: 15562129.
7. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes care. 1979; 2(2):120-6. Epub 1979/03/01. PMID: 520114.
8. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008; 371(9626):1800-9. Epub 2008/05/27. doi: 10.1016/S0140-6736 (08)60768-0 PMID: 18502305; PubMed Central PMCID: PMC2774464.
9. Breslow JL. Mouse models of atherosclerosis. Science. 1996; 272(5262):685-8. Epub 1996/05/03.PMID: 8614828.
10. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, et al. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation. 2011; 123(9):989-98. Epub 2011/02/23. doi: 10.1161/ CIRCULATIONAHA.110.984146 PMID: 21339485; PubMed Central PMCID: PMC3131163.
11. Smithies O, Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proceedings of the National Academy of Sciences of the United States of America. 1995; 92(12):5266-72. Epub 1995/06/06. PMID: 7777495; PubMed Central PMCID: PMC41675.
12. Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. The Journal of clinical investigation. 2010; 120(12):4415-24. Epub 2010/11/03. doi: 10. 1172/JCI38911 PMID: 21041949; PubMed Central PMCID: PMC2993578.
13. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes & development. 2000; 14(22):2819-30. Epub 2000/11/23. PMID: 11090130; PubMed Central PMCID: PMC317055.
14. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochemical and biophysical research communications. 2000; 274(3):794-802. Epub 2000/08/05. doi: 10.1006/bbrc.2000.3243 PMID: 10924356.
15. Gabbi C, Warner M, Gustafsson JA. Action mechanisms of Liver X Receptors. Biochemical and biophysical research communications. 2014; 446(3):647-50. Epub 2013/12/05. doi: 10.1016/j.bbrc.2013. 11.077 PMID: 24300092.
16. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996; 383(6602):728-31. Epub 1996/10/24. doi: 10.1038/ 383728a0 PMID: 8878485.
17. Teboul M, Enmark E, Li Q, Wikstrom AC, Pelto-Huikko M, Gustafsson JA. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proceedings of the National Academy of Sciences of the United States of America. 1995; 92(6):2096-100. Epub 1995/03/ 14. PMID: 7892230; PubMed Central PMCID: PMC42430.
18. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes & development. 1995; 9(9):1033-45. Epub 1995/ 05/01. PMID: 7744246.
19. Parathath S, Grauer L, Huang LS, Sanson M, Distel E, Goldberg IJ, et al. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes. 2011; 60(6):1759-69. Epub 2011/05/13. doi: 10.2337/db10-0778 PMID: 21562077; PubMed Central PMCID: PMC3114401.
20. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular cell. 2001; 7 (1):161-71. Epub 2001/02/15. PMID: 11172721.
21. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. The Journal of biological chemistry. 2000; 275(36):28240-5. Epub 2000/06/20. doi: 10.1074/jbc.M003337200 PMID: 10858438.
22. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, et al. Role of LXRs in control of lipogenesis. Genes & development. 2000; 14(22):2831-8. Epub 2000/11/23. PMID: 11090131; PubMed Central PMCID: PMC317060.
23. Jenuwein T, Allis CD. Translating the histone code. Science. 2001; 293(5532):1074-80. Epub 2001/ 08/11. doi: 10.1126/science.1063127 PMID: 11498575.
24. Lachner M, O'Sullivan RJ, Jenuwein T. An epigenetic road map for histone lysine methylation. Journal of cell science. 2003; 116(Pt 11):2117-24. Epub 2003/05/06. doi: 10.1242/jcs.00493 PMID: 12730288.
25. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 1976; 193(4251):415-7. Epub 1976/07/30. PMID: 180605.
26. Meyer R, Wolf SS, Obendorf M. PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor. The Journal of steroid biochemistry and molecular biology. 2007; 107(1-2):1-14. Epub 2007/06/26. doi: 10.1016/j.jsbmb.2007.05.006 PMID: 17587566.
27. Qi C, Chang J, Zhu Y, Yeldandi AV, Rao SM, Zhu YJ. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. The Journal of biological chemistry. 2002; 277 (32):28624-30. Epub 2002/06/01. doi: 10.1074/jbc.M201053200 PMID: 12039952.
28. Torra IP, Ismaili N, Feig JE, Xu CF, Cavasotto C, Pancratov R, et al. Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Molecular and cellular biology. 2008; 28(8):2626-36. Epub 2008/02/06. doi: 10.1128/MCB.01575-07 PMID: 18250151; PubMed Central PMCID: PMC2293109.
29. Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo CL, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. The Journal of clinical investigation. 2011; 121(10):4138-49. Epub 2011/10/05. doi: 10.1172/JCI57559 PMID: 21968112; PubMed Central PMCID: PMC3195472.
30. Yoshimoto T, Boehm M, Olive M, Crook MF, San H, Langenickel T, et al. The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Experimental cell research. 2006; 312(11):2040-53.Epub 2006/04/18. doi: 10.1016/j.yexcr.2006.03.001 PMID: 16616919.
31. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome research. 2009; 19(12):2163-71. Epub 2009/10/06. doi: 10.1101/gr.097022.109 PMID: 19801529; PubMed Central PMCID: PMC2792167.
32. Sparrow CP, Baffic J, Lam MH, Lund EG, Adams AD, Fu X, et al. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. The Journal of biological chemistry. 2002; 277(12):10021-7. Epub 2002/01/16. doi: 10.1074/jbc. M108225200 PMID: 11790770.
33. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009; 58(5):1229-36. Epub 2009/02/12. doi: 10.2337/db08-1666 PMID: 19208907; PubMed Central PMCID: PMC2671038.
34. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. The Journal of experimental medicine. 2008; 205(10):2409-17. Epub 2008/09/24. doi: 10.1084/jem. 20081188 PMID: 18809715; PubMed Central PMCID: PMC2556800.
35. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Molecular cell. 2009; 33(1):1-13. Epub 2009/01/20. doi: 10.1016/j.molcel.2008.12.013 PMID: 19150423; PubMed Central PMCID: PMC3372459.
36. Ziller MJ, Gu H, Muller F, Donaghey J, Tsai LT, Kohlbacher O, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013; 500(7463):477-81. Epub 2013/08/09. doi: 10. 1038/nature12433 PMID: 23925113; PubMed Central PMCID: PMC3821869.
37. Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nature reviews Cancer. 2013; 13(1):37-50. Epub 2012/12/14. doi: 10.1038/nrc3409 PMID: 23235912.
38. Lakowski TM, Frankel A. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4. The Biochemical journal. 2009; 421(2):253-61. Epub 2009/05/02. doi: 10.1042/BJ20090268 PMID: 19405910.
39. Le DD, Fujimori DG. Protein and nucleic acid methylating enzymes: mechanisms and regulation. Current opinion in chemical biology. 2012; 16(5-6):507-15. Epub 2012/10/23. doi: 10.1016/j.cbpa.2012. 09.014 PMID: 23085277; PubMed Central PMCID: PMC3545634.
40. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nature reviews Immunology. 2013; 13(10):709-21. Epub 2013/09/03. doi: 10.1038/nri3520 PMID: 23995626; PubMed Central PMCID: PMC4357520.
41. Miao F, Chen Z, Zhang L, Wang J, Gao H, Wu X, et al. RNA-sequencing analysis of high glucosetreated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiological genomics. 2013; 45(7):287-99. Epub 2013/02/07. doi: 10.1152/physiolgenomics.00001.2013PMID: 23386205; PubMed Central PMCID: PMC3633422.
42. Barrero MJ, Malik S. Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Molecular cell. 2006; 24(2):233-43. Epub 2006/10/21. doi: 10.1016/j. molcel.2006.09.020 PMID: 17052457; PubMed Central PMCID: PMC1647399.
43. Le GoffW. ZhengP. BrubakerG. SmithJ.D.Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: Requirement for CREB1 and STAT3/4 elementsArteriosclerosis, thrombosis, and vascular biology.2006263527-533Epub 2005/12/24 PMID: 1637361310.1161/01.ATV.0000201042.00725.84
44. Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(29):10161-6. Epub 2008/07/16. doi: 10.1073/pnas.0800796105 PMID: 18626018; PubMed Central PMCID: PMC2481316.
45. Jakobsson T, Venteclef N, Toresson G, Damdimopoulos AE, Ehrlund A, Lou X, et al. GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Molecular cell. 2009; 34(4):510-8. Epub 2009/06/02. doi: 10.1016/j.molcel.2009. 05.006 PMID: 19481530.
46. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al. Towards a knowledgebased Human Protein Atlas. Nature biotechnology. 2010; 28(12):1248-50. Epub 2010/12/09. doi: 10. 1038/nbt1210-1248 PMID: 21139605.
47. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, et al. Architecture of the human regulatory network derived from ENCODE data. Nature. 2012; 489(7414):91-100. Epub 2012/09/08. doi: 10.1038/nature11245 PMID: 22955619; PubMed Central PMCID: PMC4154057.
48. Iwasaki H, Kovacic JC, Olive M, Beers JK, Yoshimoto T, Crook MF, et al. Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circulation research. 2010; 107(8):992-1001. Epub 2010/08/28. doi: 10.1161/ CIRCRESAHA.110.225326 PMID: 20798359; PubMed Central PMCID: PMC2997704.